Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oveporexton in Narcolepsy Type 2
NCT05687916Phase 2Completed
- Sponsor
- Takeda
- Start
- Jan 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of oveporexton in narcolepsy type 2 (NT2), sponsored by Takeda. Started Jan 2023; status: completed.
02
Drugs
oveporexton
03
Conditions
narcolepsy type 2 (NT2)
Beyond the preview
Go deeper on NCT05687916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05687916.